ロード中...

Vildagliptin reduces plasma stromal cell‐derived factor‐1α in patients with type 2 diabetes compared with glimepiride

AIMS/INTRODUCTION: Dipeptidyl peptidase‐4 inhibitors might have pleiotropic protective effects on cardiovascular disease (CVD), in contrast to sulfonylureas. Therefore, we compared various CVD risk factors between vildagliptin and glimepiride. MATERIALS AND METHODS: We carried out a randomized, pros...

詳細記述

保存先:
書誌詳細
出版年:J Diabetes Investig
主要な著者: Park, Kyeong Seon, Kwak, SooHeon, Cho, Young Min, Park, Kyong Soo, Jang, Hak C, Kim, Seong Yeon, Jung, Hye Seung
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5334315/
https://ncbi.nlm.nih.gov/pubmed/27575011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12572
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!